Back to medications
Medication monograph
tofacitinib
Janus Kinase (JAK) InhibitorsDisease-Modifying Antirheumatic Drugs (DMARDs)Janus Kinase (JAK) InhibitorsDisease-modifying Antirheumatic AgentsJanus Kinase InhibitorImmunomodulatory AgentsDisease-modifying Antirheumatic Drugs
Clinical reference
Product monograph
XELJANZ- tofacitinib tablet, film coatedXELJANZ XR- tofacitinib tablet, film coated, extended releaseXELJANZ- tofacitinib solution
XELJANZ- tofacitinib tablet, film coatedXELJANZ XR- tofacitinib tablet, extended release
Brands & formulations
Family members
XELJANZ XR
Marketed11 MGORALTABLET (EXTENDED-RELEASE)[
"tofacitinib (tofacitinib citrate)"
]
Product monograph TARO-TOFACITINIB XR
Marketed11 MGORALTABLET (EXTENDED-RELEASE)[
"tofacitinib (tofacitinib citrate)"
]
Product monograph Pricing
Price information
Xeljanz Tablet
Pfizer · 5 mg
: $
Xeljanz Tablet
Pfizer · 10 mg
: $
Xeljanz XR Tablet
Pfizer · 11 mg
: $
Tofacitinib Tablet
Generic · 5 mg
60: $714.27
Tofacitinib Tablet
Generic · 10 mg
60: $2712.84
Tofacitinib XR Tablet
Generic · 11 mg
30: $1785.760: $3571.41
Classification
- Chemical class
- Janus Kinase (JAK) Inhibitors
- Clinical class
- Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors
- Banks class
- Disease-modifying Antirheumatic Agents, Janus Kinase Inhibitor
- AHFS family
- Immunomodulatory Agents, Disease-modifying Antirheumatic Drugs